Phibro Animal Health Corporation
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including po… Read more
Phibro Animal Health Corporation (PAHC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.058x
Based on the latest financial reports, Phibro Animal Health Corporation (PAHC) has a cash flow conversion efficiency ratio of 0.058x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($19.35 Million) by net assets ($332.36 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Phibro Animal Health Corporation - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Phibro Animal Health Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Phibro Animal Health Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Phibro Animal Health Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fibra Danhos
MX:DANHOS13
|
0.022x |
|
THANACHART CAP.-FGN-BA 10
F:NFPH
|
N/A |
|
Oesterr. Post AG
VI:POST
|
0.083x |
|
Nagase & Company Ltd
OTCMKTS:NGSCF
|
N/A |
|
Shanghai Chengdi Constr Co
SHG:603887
|
0.201x |
|
LIBERTY LAT.AMER.C DL-01
F:1LLC
|
N/A |
|
Donnelley Financial Solutions Inc
NYSE:DFIN
|
0.176x |
|
DL E&C Co Ltd
KO:375500
|
0.015x |
Annual Cash Flow Conversion Efficiency for Phibro Animal Health Corporation (2000–2025)
The table below shows the annual cash flow conversion efficiency of Phibro Animal Health Corporation from 2000 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $285.68 Million | $80.12 Million | 0.280x | -17.83% |
| 2024-06-30 | $256.64 Million | $87.59 Million | 0.341x | +624.44% |
| 2023-06-30 | $282.51 Million | $13.31 Million | 0.047x | -60.93% |
| 2022-06-30 | $262.44 Million | $31.65 Million | 0.121x | -40.45% |
| 2021-06-30 | $238.53 Million | $48.31 Million | 0.203x | -35.78% |
| 2020-06-30 | $188.20 Million | $59.35 Million | 0.315x | +44.41% |
| 2019-06-30 | $216.01 Million | $47.17 Million | 0.218x | -42.31% |
| 2018-06-30 | $184.95 Million | $70.01 Million | 0.379x | -41.85% |
| 2017-06-30 | $151.16 Million | $98.40 Million | 0.651x | +58.26% |
| 2016-06-30 | $90.48 Million | $37.22 Million | 0.411x | -82.26% |
| 2015-06-30 | $29.63 Million | $68.70 Million | 2.319x | +5033.82% |
| 2014-06-30 | $15.15 Million | $-712.00K | -0.047x | -680.74% |
| 2013-06-30 | $-68.94 Million | $415.00K | -0.006x | +98.34% |
| 2012-06-30 | $-88.23 Million | $31.99 Million | -0.363x | +51.24% |
| 2009-06-30 | $-53.88 Million | $40.06 Million | -0.744x | -1483.27% |
| 2007-06-30 | $-88.00 Million | $-4.73 Million | 0.054x | +655.42% |
| 2006-06-30 | $-83.70 Million | $810.00K | -0.010x | -107.05% |
| 2005-06-30 | $-44.90 Million | $-6.16 Million | 0.137x | +406.05% |
| 2004-06-30 | $-63.80 Million | $2.86 Million | -0.045x | +89.06% |
| 2003-06-30 | $-84.60 Million | $34.66 Million | -0.410x | -627.86% |
| 2002-06-30 | $-61.20 Million | $-4.75 Million | 0.078x | -97.99% |
| 2001-06-30 | $3.40 Million | $13.14 Million | 3.865x | +1648.81% |
| 2000-06-30 | $31.70 Million | $-7.91 Million | -0.250x | -- |